×
Eli Lilly Inventory 2010-2024 | LLY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Eli Lilly inventory for the quarter ending September 30, 2024 was
$7.460B
, a
52.2% increase
year-over-year.
Eli Lilly inventory for 2023 was
$5.773B
, a
33.95% increase
from 2022.
Eli Lilly inventory for 2022 was
$4.31B
, a
10.9% increase
from 2021.
Eli Lilly inventory for 2021 was
$3.886B
, a
2.37% decline
from 2020.
View More
Eli Lilly Inventory 2010-2024 | LLY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Eli Lilly inventory for 2023 was
$5.773B
, a
33.95% increase
from 2022.
Eli Lilly inventory for 2022 was
$4.31B
, a
10.9% increase
from 2021.
Eli Lilly inventory for 2021 was
$3.886B
, a
2.37% decline
from 2020.
Related Stocks
Company Name
Market
Cap
Novo Nordisk (NVO)
$460.6B
Johnson & Johnson (JNJ)
$368.4B
AbbVie (ABBV)
$294.4B
Merck (MRK)
$244.2B
Novartis AG (NVS)
$211.1B
AstraZeneca (AZN)
$197.8B
Pfizer (PFE)
$142.2B
Sanofi (SNY)
$121.8B
Innoviva (INVA)
$1.2B